Related Experiment Video
Updated: Jul 16, 2026
08:37
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Covert suppressor T cells in Crohn's disease
Gastroenterology
|June 1, 1981
Summary
Patients with Crohn's disease do not have a suppressor T-cell deficiency. Instead, purified T cells from these patients reveal a marked inhibition of immunoglobulin M synthesis, indicating a regulatory defect in immune cells.
Area of Science:
- Immunology
- Gastroenterology
Background:
- Immune dysregulation is implicated in Crohn's disease pathogenesis.
- Suppressor T cells play a critical role in maintaining immune homeostasis.
Purpose of the Study:
- To investigate potential defects in suppressor T-cell activity in patients with Crohn's disease.
- To assess the role of T cells in regulating immunoglobulin M (IgM) synthesis in Crohn's disease.
Main Methods:
- Assessed suppressor T-cell activity in 16 Crohn's disease patients and 16 healthy controls.
- Utilized pokeweed mitogen-stimulated peripheral blood lymphocyte cultures.
- Performed co-cultures of purified B cells and T cells from patients and controls.
- Measured immunoglobulin M (IgM) synthesis.
Main Results:
- Whole lymphocyte cultures showed normal IgM synthesis and no altered regulation between patient and control cells.
- Cultures with purified B and T cells from Crohn's disease patients synthesized significantly less IgM compared to controls (p < 0.005).
- A suppressor T cell, revealed during purification, markedly inhibited IgM synthesis in at least half of the patients.
Conclusions:
- Patients with Crohn's disease do not exhibit a deficiency in suppressor T cells regulating antibody synthesis.
- A subset of Crohn's disease patients possess suppressor T cells that inhibit IgM synthesis, but this activity is masked in unpurified lymphocyte cultures.
- These findings suggest an in vitro-revealed regulatory T-cell abnormality in Crohn's disease immune responses.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...